INTERIM RESULTS FROM A PHASE 1B DOSE-ESCALATION STUDY OF 4 WEEKS OF PEG-INTERFERON LAMBDA (PEG-RIL-29) TREATMENT IN SUBJECTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE 1 WITH PRIOR VIROLOGIC RESPONSE AND RELAPSE TO PEGINTERFERON ALFA AND RIBAVIRIN

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Lawitz, EJ; Zaman, A; Muir, AJ; Shiffman, ML; Yoffe, B; Zhang, T; Souza, S; Hausman, DF

Published Date

  • October 1, 2008

Published In

Volume / Issue

  • 48 / 4

Start / End Page

  • 385A - 385A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Conference Location

  • San Francisco, CA

Conference Start Date

  • October 31, 2008

Conference End Date

  • November 4, 2008